U.S. flag

An official website of the United States government

NM_002691.4(POLD1):c.961G>A (p.Gly321Ser) AND Hereditary cancer-predisposing syndrome

Germline classification:
Conflicting interpretations of pathogenicity (3 submissions)
Last evaluated:
Nov 3, 2021
Review status:
criteria provided, conflicting classifications
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000564226.9

Allele description [Variation Report for NM_002691.4(POLD1):c.961G>A (p.Gly321Ser)]

NM_002691.4(POLD1):c.961G>A (p.Gly321Ser)

Gene:
POLD1:DNA polymerase delta 1, catalytic subunit [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19q13.33
Genomic location:
Preferred name:
NM_002691.4(POLD1):c.961G>A (p.Gly321Ser)
HGVS:
  • NC_000019.10:g.50402732G>A
  • NG_033800.1:g.23410G>A
  • NM_001256849.1:c.961G>A
  • NM_001308632.1:c.961G>A
  • NM_002691.4:c.961G>AMANE SELECT
  • NP_001243778.1:p.Gly321Ser
  • NP_001295561.1:p.Gly321Ser
  • NP_002682.2:p.Gly321Ser
  • LRG_785t1:c.961G>A
  • LRG_785t2:c.961G>A
  • LRG_785:g.23410G>A
  • LRG_785p1:p.Gly321Ser
  • LRG_785p2:p.Gly321Ser
  • NC_000019.9:g.50905989G>A
  • NM_002691.2:c.961G>A
  • NM_002691.3:c.961G>A
  • NM_002691.4:c.961G>A
  • NR_046402.2:n.1006G>A
Protein change:
G321S
Links:
dbSNP: rs41554817
NCBI 1000 Genomes Browser:
rs41554817
Molecular consequence:
  • NM_001256849.1:c.961G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001308632.1:c.961G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_002691.4:c.961G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NR_046402.2:n.1006G>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Hereditary cancer-predisposing syndrome
Synonyms:
Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000670900Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Likely benign
(Nov 3, 2021)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Citation Link,

SCV000788156True Health Diagnostics
no assertion criteria provided
Uncertain significance
(Sep 29, 2017)
germlineclinical testing

SCV002534716Sema4, Sema4
criteria provided, single submitter

(Sema4 Curation Guidelines)
Uncertain significance
(Sep 9, 2021)
germlinecuration

PubMed (6)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing, curation

Citations

PubMed

A germline homozygous mutation in the base-excision repair gene NTHL1 causes adenomatous polyposis and colorectal cancer.

Weren RD, Ligtenberg MJ, Kets CM, de Voer RM, Verwiel ET, Spruijt L, van Zelst-Stams WA, Jongmans MC, Gilissen C, Hehir-Kwa JY, Hoischen A, Shendure J, Boyle EA, Kamping EJ, Nagtegaal ID, Tops BB, Nagengast FM, Geurts van Kessel A, van Krieken JH, Kuiper RP, Hoogerbrugge N.

Nat Genet. 2015 Jun;47(6):668-71. doi: 10.1038/ng.3287. Epub 2015 May 4.

PubMed [citation]
PMID:
25938944

Low frequency of POLD1 and POLE exonuclease domain variants in patients with multiple colorectal polyps.

Elsayed FA, Tops CMJ, Nielsen M, Ruano D, Vasen HFA, Morreau H, J Hes F, van Wezel T.

Mol Genet Genomic Med. 2019 Apr;7(4):e00603. doi: 10.1002/mgg3.603. Epub 2019 Mar 2.

PubMed [citation]
PMID:
30827058
PMCID:
PMC6465667
See all PubMed Citations (6)

Details of each submission

From Ambry Genetics, SCV000670900.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From True Health Diagnostics, SCV000788156.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Sema4, Sema4, SCV002534716.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcuration PubMed (6)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 10, 2024